Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Oral manifestations of Covid-19-A literature review.

Tytuł:
Oral manifestations of Covid-19-A literature review.
Autorzy:
Farid H; Margalla Institute of Health Sciences, Rawalpindi, Pakistan.
Khan M; Aga Khan University Hospital, Karachi, Pakistan.
Jamal S; Aga Khan University Hospital, Karachi, Pakistan.
Ghafoor R; Aga Khan University Hospital, Karachi, Pakistan.
Źródło:
Reviews in medical virology [Rev Med Virol] 2022 Jan; Vol. 32 (1), pp. e2248. Date of Electronic Publication: 2021 May 24.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Chichester, West Sussex, England : Wiley, c1991-
MeSH Terms:
Xerostomia*/immunology
Xerostomia*/virology
COVID-19/*complications
Mouth Diseases/*virology
Mouth Mucosa/*pathology
Taste Disorders/*virology
Angiotensin-Converting Enzyme 2/blood ; Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/immunology ; Dysgeusia/virology ; Humans ; Mouth Diseases/pathology ; Mouth Mucosa/virology ; SARS-CoV-2
References:
Oral Dis. 2021 Apr;27 Suppl 3:768-769. (PMID: 32506662)
Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Sep;130(3):344-346. (PMID: 32703719)
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11. (PMID: 32369429)
Braz Oral Res. 2020 Oct 30;34:e124. (PMID: 33146320)
Tidsskr Nor Laegeforen. 2020 Apr 03;140(7):. (PMID: 32378854)
Am J Otolaryngol. 2020 Sep - Oct;41(5):102612. (PMID: 32574896)
J Clin Med. 2021 Feb 04;10(4):. (PMID: 33557130)
Nat Microbiol. 2020 Apr;5(4):536-544. (PMID: 32123347)
Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134. (PMID: 32340555)
Oral Dis. 2021 Apr;27 Suppl 3:779-780. (PMID: 32521067)
Euro Surveill. 2020 Feb;25(5):. (PMID: 32046819)
Clin Infect Dis. 2020 Jul 28;71(15):889-890. (PMID: 32215618)
Br J Dermatol. 2020 Jul;183(1):71-77. (PMID: 32348545)
J Gen Intern Med. 2020 May;35(5):1545-1549. (PMID: 32133578)
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):1114-1134. (PMID: 33577069)
Int J Infect Dis. 2020 Aug;97:326-328. (PMID: 32526392)
Rev Med Virol. 2022 Jan;32(1):e2248. (PMID: 34028129)
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e299-e300. (PMID: 32314436)
Am J Otolaryngol. 2021 May-Jun;42(3):102905. (PMID: 33497914)
Obesity (Silver Spring). 2020 May;28(5):848. (PMID: 32237199)
Dermatol Ther. 2020 Sep;33(5):e13549. (PMID: 32390279)
Methods Mol Biol. 2015;1282:v. (PMID: 25870870)
Clin Exp Dermatol. 2020 Oct;45(7):892-895. (PMID: 32385858)
Eur J Case Rep Intern Med. 2020 Apr 03;7(4):001641. (PMID: 32309267)
Oral Dis. 2021 Apr;27 Suppl 3:748-749. (PMID: 32333489)
Br J Dermatol. 2020 Sep;183(3):431-442. (PMID: 32479680)
J Med Virol. 2021 Jan;93(1):129-132. (PMID: 32579237)
Dermatol Ther. 2021 Jan;34(1):e14717. (PMID: 33368888)
Oral Dis. 2021 Apr;27 Suppl 3:770. (PMID: 32506730)
Front Med (Lausanne). 2021 Jan 14;7:571214. (PMID: 33521007)
Clin Cosmet Investig Dent. 2021 Feb 18;13:47-50. (PMID: 33628060)
Otolaryngol Head Neck Surg. 2020 Oct;163(4):722-728. (PMID: 32539587)
Oral Dis. 2021 Apr;27 Suppl 3:710-712. (PMID: 32369674)
Oral Dis. 2021 Apr;27 Suppl 3:771-772. (PMID: 32510821)
J Clin Med. 2021 Feb 13;10(4):. (PMID: 33668602)
Oral Dis. 2022 Apr;28 Suppl 1:988-990. (PMID: 32889763)
Int J Oral Sci. 2020 Feb 24;12(1):8. (PMID: 32094336)
Am Fam Physician. 2013 Dec 15;88(12):852-9. (PMID: 24364550)
Nature. 2020 Mar;579(7798):265-269. (PMID: 32015508)
Contributed Indexing:
Keywords: Covid-19; dry mouth; gustatory changes; mucosal lesions; oral manifestations
Substance Nomenclature:
EC 3.4.17.23 (ACE2 protein, human)
EC 3.4.17.23 (Angiotensin-Converting Enzyme 2)
Entry Date(s):
Date Created: 20210524 Date Completed: 20220124 Latest Revision: 20220716
Update Code:
20240105
PubMed Central ID:
PMC8209937
DOI:
10.1002/rmv.2248
PMID:
34028129
Czasopismo naukowe
Initially, it was reported that coronavirus 2019 disease (Covid-19) affects respiratory, gastrointestinal and neurological systems, but the oral, olfactory and integumentary systems are also involved. This review discusses various oral manifestations of Covid-19 reported in the literature along with possible underlying mechanisms. The reported manifestations include taste impairment, oral mucosal changes (petechiae, ulcers, plaque-like lesions, reactivation of herpes simplex virus 1(HSV1), geographical tongue and desquamative gingivitis) and dry mouth. The prominent location for mucosal lesions are tongue, palate and labial mucosa. The exact pathogenesis of these oral symptoms is not known. Angiotensin-converting enzyme 2 (ACE2) cell receptors are expressed in abundance on oral mucosa allowing severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) to infect them. Gustatory impairment along with olfactory changes is now listed as a symptom of Covid-19 by the World Health Organization, but further research is needed to confirm a link between reported additional oral symptoms and Covid-19. Dental professionals may encounter individuals with Covid-19 and be called upon to identify various oral manifestations of this disease.
(© 2021 John Wiley & Sons Ltd.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies